897043-85-5

Basic information

• Product Name: 3-Methyl-4-oxo-1,3-pyrrolidinedicarboxylic acid 1-(tert-butyl) 3-ethyl ester
• Synonyms: 3-Methyl-4-oxo-1,3-pyrrolidinedicarboxylic acid 1-(tert-butyl) 3-ethyl ester;3-Methyl-4-oxo-pyrrolidine-1,3-dicarboxylic acid-1-tert-butyl ester-3-ethyl ester;Ethyl 1-Boc-3-methyl-4-oxopyrrolidine-3-carboxylate
• CAS NO: 897043-85-5
• Molecular Formula: C₁₃H₂₁NO₅
• Molecular Weight: 272.31748
• Mol File: 897043-85-5.mol
• Article Data: 6

Chemical Properties

• Appearance: /
• Density: 1.149
• CAS DataBase Reference: 3-Methyl-4-oxo-1,3-pyrrolidinedicarboxylic acid 1-(tert-butyl) 3-ethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 3-Methyl-4-oxo-1,3-pyrrolidinedicarboxylic acid 1-(tert-butyl) 3-ethyl ester(897043-85-5)
• EPA Substance Registry System: 3-Methyl-4-oxo-1,3-pyrrolidinedicarboxylic acid 1-(tert-butyl) 3-ethyl ester(897043-85-5)

Safety Data

• Hazardous Substances Data: 897043-85-5(Hazardous Substances Data)

Usage

General Description

3-Methyl-4-oxo-1,3-pyrrolidinedicarboxylic acid 1-(tert-butyl) 3-ethyl ester is a chemical compound with the molecular formula C13H21NO5. It is a derivative of 1,3-pyrrolidinedicarboxylic acid and is commonly used as a building block in organic synthesis. 3-Methyl-4-oxo-1,3-pyrrolidinedicarboxylic acid 1-(tert-butyl) 3-ethyl ester is a white to off-white crystalline solid with a molecular weight of 275.31 g/mol. It is often used in the pharmaceutical industry for the synthesis of various drugs and pharmaceutical compounds. Additionally, it has potential applications in the field of medicinal chemistry and drug discovery.

Upstream product

• 146256-98-6 4-oxo-pyrrolidine-1,3-dicarboxylic acid 1-tert-butyl ester 3-ethyl ester 
• 74-88-4 methyl iodide 
• 24424-99-5 di-tert-butyl dicarbonate 
• 14719-37-0 ethyl 2-(tert-butoxycarbonylamino)acetate 

Relevant articles and documents

Novel stereoselective synthesis of all four diastereomers of 3a-methyl-pyrrolo[3,4-c]piperidine from glycine ethyl ester

Asymmetric synthesis of all four diastereomers of 3a-methyl-pyrrolo[3,4-c]piperidine is described herein. The key steps in this synthesis are the highly diastereoselective hydrogenation of an alkenyl nitrile through a hydroxyl-directed or sterically contr

CYCLIC COMPOUNDS AND METHODS OF USING SAME

The present application relates to compounds of Formula (I), as defined herein, and pharmaceutically acceptable salts thereof which are MALT1 inhibitors. The present application also describes pharmaceutical composition comprising a compound of Formula (I), and pharmaceutically acceptable salts thereof, and methods of using the compounds and compositions for treating diseases, such as cancer, autoimmune disorders, and inflammatory disorders.

Synthesis, antimycobacterial and antibacterial activity of fluoroquinolone derivatives containing an 3-alkoxyimino-4-(cyclopropylanimo)methylpyrrolidine moiety

A series of novel fluoroquinolone derivatives containing an 3-alkoxyimino-4-(cyclopropylanimo)methylpyrrolidine moiety were designed, synthesized and evaluated for their biological activity. Our results revealed that 19b2 shows good activity against MTB H